Mechanisms of Lipoprotein(a) Pathogenicity
- 1 July 2012
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 32 (7), 1550-1551
- https://doi.org/10.1161/atvbaha.112.251306
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Genetic Variation in LPAL2 , LPA , and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease RiskStroke, 2011
- Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and ChildrenCirculation, 2010
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial InfarctionJama-Journal Of The American Medical Association, 2009
- Genetically Elevated C-Reactive Protein and Ischemic Vascular DiseaseThe New England Journal of Medicine, 2008
- Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque AreaArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Lipoprotein (a) and Venous Thromboembolism in Adults: A Meta-AnalysisAmerican Journal Of Medicine, 2007
- Cardiovascular Risk Factors and Venous Thromboembolism IncidenceArchives of Internal Medicine, 2002
- Compensatory Enlargement of Human Atherosclerotic Coronary ArteriesThe New England Journal of Medicine, 1987
- ThrombogenesisThe New England Journal of Medicine, 1967